Welcome Message
- Welcome Message
Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai.
Head of Central IPC, EHS
National AMR Committee Co-Chair
Dubai, United Arab Emirates
Dear Friends & Colleagues,
It is my great pleasure to invite you to the 9th UAE International Conference on Antimicrobial Resistance (ICAMR 2026), which will take place on 10 & 11 April 2026, at the prestigious Jumeirah Emirates Towers, Dubai, United Arab Emirates.
Over the past eight years, this annual gathering organized by the Ministry of Health and Prevention (MOHAP) has flourished under the esteemed patronage of H.E. Abdul Rahman Al Owais, Minister of Health and Prevention, UAE. The conference is also a key initiative of the UAE National AMR Committee, chaired by H.E. Dr. Hussain Abdulrahman Al Rand, Assistant Undersecretary for Public Health, MOHAP. We are proud to continue this legacy with ICAMR 2026.
ICAMR 2026 promises to be an enriching scientific and educational experience, highlighting the latest advances in research and practice through expert presentations, interactive discussions and high-level networking. With a strong focus on antimicrobial resistance, the conference will feature comprehensive, high-quality scientific content and is proudly organized by the National Antimicrobial Resistance Committee in the UAE.
We are confident that ICAMR 2026 will provide an exceptional platform for participants to share insights and expertise across microbiology, infectious diseases, infection prevention and control, and antimicrobial stewardship. It will also be an invaluable opportunity to engage with leading experts and innovative educators from around the world.
We look forward to welcoming you to the 9th ICAMR in 2026.
Global Health Leader (2025)
Supported by (2025)
In Collaboration with (2025)
Endorsed By (2025)
In Compliance with
Scientific & Organizing Committee
Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai.
Head of Central IPC, EHS
National AMR Committee Co-Chair
Dubai, UAE
Dr. Ahmed Al Hammadi
Consultant, Infectious Disease
President, Emirates Infectious Disease Society
Infectious Disease
Al Rahba Hospital
Abu Dhabi, UAE
Dr. Majid Al Shamrani
Executive Director
Infection Prevention & Control Program
King Abdulaziz Medical City
Ministry of National Guard Health Affairs
Riyadh, KSA
Dr. Jameela Alsalman
Chaiperson, Medical Dept. & Director of Quality
Patient Safety & Infection Control
King Hamad American Mission Hospital
Prof. of Medicine, Arabian Gulf University
Chairperson of Strategic Advisory Committee, WHO
Manama, Bahrain
Dr. Ashraf Elhoufy
Consultant Head ICU Al Zahra Hospital Dubai
Professor of |medicine Dubai Medical College
Examiner for the Royal College of Physician (UK)
Vice President of Emirates Intensive Care Society
Dubai, UAE
Prof. Souha S. Kanj
MD, FACP, FIDSA, FRCP, FESCMI, FECMM, FISAC
Professor of Medicine and Infectious Diseases
Chairperson, Infection Control Program,
Co-Director, Antimicrobial Stewardship Program
American University of Beirut Medical Center, Lebanon,
President , International Society of Antimicrobial Chemotherapy (ISAC)
Consultant Professor, Duke University, Medical Center, USA
Honorary Dr., Radboud University
Medical Center, NL
Ms. Abeer Rajeh Khalil
RN-BSN,CIC
Infection control Expert
Quality and Accreditation Department
Emirates Health Services
Dubai, UAE
Dr. Faryal Khamis
Senior Consultant Adult ID and Deputy Director of Medicine
Internal Medicine
Royal Hospital
Muscat, Oman
Ms. Husna Nazar
Medical Secretary
Al Kuwait Hospital Dubai
Dubai, UAE
Mr. Joseph Tannous
Infection Control Specialist
CBIC International Director
Emirates Health Services
Dubai, UAE
Dr. Najiba M Abdulrazzaq
Consultant Internist
Head of Medical Dept.
Al Kuwait Hospital Dubai.
Head of Central IPC, EHS
National AMR Committee Co-Chair
Dubai, UAE
Dr. Layla Al-Dabal
BSc, MD MSc (UK) FRCP (UK)
Consultant
Medical-Infectious Diseases
Rashid Hospital
Dubai, UAE
Dr. Nehad Alshirawi
MD, MRCP UK, EDIC, Saudi Fellowship in ICU. Diploma in health care management
Consultant ICU
Chair – National UAE antimicrobial Stewardship Committee
Al Fujairah Hospital
Fujairah, UAE
Dr. Ashraf Elhoufy
Consultant Head ICU Al Zahra Hospital Dubai
Professor of |medicine Dubai Medical College
Examiner for the Royal College of Physician (UK)
Vice President of Emirates Intensive Care Society
Dubai, UAE
Prof. Souha S. Kanj
MD, FACP, FIDSA, FRCP, FESCMI, FECMM, FISAC
Professor of Medicine and Infectious Diseases
Chairperson, Infection Control Program,
Co-Director, Antimicrobial Stewardship Program
American University of Beirut Medical Center, Lebanon,
President , International Society of Antimicrobial Chemotherapy (ISAC)
Consultant Professor, Duke University, Medical Center, USA
Honorary Dr., Radboud University
Medical Center, NL
Dr. Ahmad Lutfi Subhi
Infectious Disease Consultant
Al-Qassimi hospital, EHS
Sharjah, UAE
Mr. Joseph Tannous
Infection Control Specialist
CBIC International Director
Emirates Health Services
Dubai, UAE
Dr. Elias Tannous
PhD, MBA, BSN, CIC
Manager, Infection Prevention and Control Program
Co-Chair, Infection Control Committee
Cleveland Clinic Abu Dhabi
Abu Dhabi, UAE
Dr. Sohanlal Thiruvoth
Infection control Unit Head,
Kuwait Hospital,
Sharjah, UAE
Dr. Jehad Abdalla
ID Consultant, SKMC Hospital
Chair of ASP Committee in SEHA
Abu Dhabi, UAE
Dr. Majid Al Shamrani
Executive Director
Infection Prevention & Control Program
King Abdulaziz Medical City
Ministry of National Guard Health Affairs
Riyadh, KSA
Dr. Adnan AlAtoom
Consultant physician, clinical pathology and microbiology
Head of AJCH and Latifa laboratories
Dubai health
Dubai, UAE
Dr. Layla Al-Dabal
BSc, MD MSc (UK) FRCP (UK)
Consultant
Medical-Infectious Diseases
Rashid Hospital
Dubai, UAE
Dr. Jameela Alsalman
Chaiperson, Medical Dept. & Director of Quality
Patient Safety & Infection Control
King Hamad American Mission Hospital
Prof. of Medicine, Arabian Gulf University
Chairperson of Strategic Advisory Committee, WHO
Manama, Bahrain
Dr. Ashraf Elhoufy
Consultant Head ICU Al Zahra Hospital Dubai
Professor of |medicine Dubai Medical College
Examiner for the Royal College of Physician (UK)
Vice President of Emirates Intensive Care Society
Dubai, UAE
Ms. Rania El-Lababidi
PharmD, EMHA, BCPS, BCIDP
Senior Manager, Pharmacy Education and Training and Co-Director of the ASP
Cleveland Clinic Abu Dhabi
Abu Dhabi, UAE
Prof. Souha S. Kanj
MD, FACP, FIDSA, FRCP, FESCMI, FECMM, FISAC
Professor of Medicine and Infectious Diseases
Chairperson, Infection Control Program,
Co-Director, Antimicrobial Stewardship Program
American University of Beirut Medical Center, Lebanon,
President , International Society of Antimicrobial Chemotherapy (ISAC)
Consultant Professor, Duke University, Medical Center, USA
Honorary Dr., Radboud University
Medical Center, NL
Ms. Abeer Rajeh Khalil
RN-BSN
Infection control Expert
Quality & Accreditation Dept.
Emirates Health Services
Dubai, UAE
Prof. Martin Kiernan
Visiting Professor
Richard Wells Research Centre
University of West London
London, UK
Dr. Ahmad Lutfi Subhi
Infectious Disease Consultant
Al-Qassimi hospital, EHS
Sharjah, UAE
Dr. Jomana Musmar
Founder and Senior Consultant
AMR Strategic Coalitions (ASC)
& Advisors of Global Health (AGH)
Washington DC, USA
Dr. Rajeev Soman
Consultant, Infectious Diseases Physician
Infectious Diseases
Jupiter Hospital
Pune, India
Mr. Joseph Tannous
Infection Control Specialist
CBIC International Director
Emirates Health Services
Dubai, UAE
Dr. Elias Tannous
PhD, MBA, BSN, CIC
Manager, Infection Prevention and Control Program
Co-Chair, Infection Control Committee
Cleveland Clinic Abu Dhabi
Abu Dhabi, UAE
Dr. Ajish Thankachan
Senior Infection Preventionist
Emirates Health Services
Dubai, UAE
Prof. Andreas Voss
Professor & Chair Medical Microbiology & Infection Control (MMBI)
University Medical Center Groningen (UMCG)
Groningen, Netherlands
Prof. Andreas Widmer
MD, MS, FIDSA, FSHEA
Founder and President National Center for Infection Prevention
Executive member roundtable antibiotics
Core member patient safety WHO,
Geneva, Switzerland
Scientific Program
Conference Main Topics
- Antimicrobial Stewardship Programs
- AMR: updates, novel technology and artificial intelligence
- Challenges and research priorities to combat AMR
- Prevention of healthcare-associated infections
- Surveillance of multidrug resistance organisms
- Implementation science for infection control
- Environmental disinfection in healthcare settings
- New antimicrobial therapies
Target Specialties:
- Infection disease physicians
- Internal medicine physicians
- Microbiologists
- Pharmacists
- Infection control practitioners
- Critical care physicians
- Lab technicians
- Quality officers
- Public health officers
- Internal medicine specialists
- Family and primary care physicians
- Medical informatics
- Nurses, nurse practitioners
- Researchers
- Biomedical engineers
- Hospital and corporate administrators and executives
Learning Objectives
- Antimicrobial Stewardship Programs: interventions and outcomes
- UAE AMR surveillance updates
- GCC: experience and strategies to combat AMR
- Strengthening country readiness for pandemics
- AMR in mass gathering and implications for public health
- Strategies, technology and artificial intelligence to combat AMR
- Challenges and research priorities to combat AMR
- Implementation of science in the fight against HAI
- Innovative approach to prevent MDRO
- Prevention and management of healthcare-associated infections
- Business case for Infection, Prevention and Control Programs
- Environmental hygiene for patient safety
- Improving healing environment in building projects
- Certification: preparation and tips for infection preventionists
Abstract Submission
Abstract Submission
To submit an abstract, please read all of the instructions below.
You are invited to submit an abstract for the 9th UAE International Conference on Antimicrobial Resistance (ICAMR) on 10th & 11th April 2026.
- Abstract Submission deadline until: Sunday, 1st March 2026 – 11:59 PM
- Notification on Acceptance/Rejection: Between 10th to 15th March 2026 – 11:59 PM
*Please note that only electronic submissions are accepted.
Language & Content
All abstracts must be submitted in English using the online submission form on website with a limit of 2,245 characters (approx. 300 words).
General Conditions
- Abstracts must be submitted maximum by Sunday, 1st March 2026 – 11:59 PM.
- Abstracts are accepted as Poster presentations only.
- All accepted abstracts will be presented as posters on 11th April 2026.
- Withdrawal of abstracts can only be accepted if notified in writing. It is possible to withdraw an abstract 14 days after notification on acceptance.
- If selected, it is the responsibility of the presenter to bear his travel and accommodation expenses.
Presenting Author and Registration
- Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
- Disclosure: Abstract submitter and presenter are required to disclose any conflict of interest.
- Ensure that all co-authors approve the abstract submission, publication, and potential presentation.
- All presenters should be registered to the conference before 25 March 2026.
- Abstract submitters must consent to the Policies of Abstract Submission.
- National Committee of AMR reserves the right to exclude any abstract from the scientific program that is not followed by a participant registration at the latest 14 days after notification on acceptance.
Original works and Case Reports about the below will be accepted:
Contents of your Abstract
- Original works and Case Reports about the below will be accepted:
• Microbiology
• Infectious Disease
• Infection Control
• Antimicrobial Resistance - The abstract text body is limited to 2,245 characters (Approx. 300 words) including spaces. (Please do not include the title and the author’s information in the text body [names and affiliations], this information will be required in the web form)
- The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
- There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present a maximum of 2 abstract (independent of the format) during the entire conference. If you have more than 2 abstracts accepted, you will be obliged to identify alternate presenters for any abstract above the first two.
- The abstract must include the following:
Aim: Clearly state the purpose of the abstract.
Methods: Describe your selection of observations or experimental subjects clearly.
Results: Present, your results in a logical sequence in text, table and illustrations.
Conclusions: Emphasize new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them. - All abbreviations must be defined in first use.
- No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of the author(s) and their institution(s), when you submit your abstract online
- Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
- Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. Conference scientific committee reserves the right to replace any brand name with a generic name without further notice.
- Images that are uploaded to follow the abstract are not guaranteed inclusion in the conference materials.
Conference Venue
Jumeirah Emirates Towers, located on Sheikh Zayed Road in the heart of Dubai’s commercial district, is a premier business hotel offering sophisticated conference and meeting facilities. With 17 versatile meeting rooms, including the spacious Godolphin Ballroom and panoramic city-view suites, it can host up to 1,000 guests and features state-of-the-art technology, natural lighting, and professional event support. Conveniently accessible via Dubai Metro and just 15 minutes from Dubai International Airport, it is ideal for corporate events, board meetings, and large conferences.
